Microbial dysbiosis and associated human diseases

Dysbiosis, a disturbance in the normal balance of microbial communities within the body, particularly the gut, is linked to various diseases. The human microbiota is essential for health, aiding digestion, synthesizing vitamins, modulating the immune system, and protecting against pathogens. Dysbiosis can result from factors like antibiotic use, dietary changes, infections, and chronic diseases, potentially leading to or worsening multiple health conditions. Gastrointestinal diseases are prominently associated with dysbiosis, Conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and colorectal cancer have shown connections to gut microbiota alterations. In IBD, for instance, patients often display reduced microbial diversity and an overgrowth of harmful bacteria, contributing to inflammation and tissue damage. In IBS, dysbiosis may affect gut motility, sensitivity, and immune responses, causing symptoms like pain, bloating, and altered bowel habits. Beyond gastrointestinal issues, dysbiosis is also implicated in metabolic disorders like obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). The gut microbiota influences energy extraction from food, fat storage, and insulin sensitivity. Dysbiosis can promote inflammation and alter metabolic pathways, thus contributing to these conditions. Certain bacterial metabolites, such as short-chain fatty acids (SCFAs), are crucial in regulating host metabolism, and imbalances in their production can impact metabolic health. Moreover, the gut-brain axis, a communication system between the gut microbiota and the brain, demonstrates the impact of dysbiosis on mental health and neurological disorders. Dysbiosis has been linked to depression, anxiety, and neurodegenerative diseases like Parkinson's and Alzheimer's. Microbial metabolites, including neurotransmitters and inflammatory molecules, can affect brain function and behaviour, underscoring the importance of gut health for mental well-being. The factors contributing to dysbiosis are varied and complex. Antibiotics, although vital for treating infections, can kill beneficial bacteria indiscriminately, leading to reduced diversity and imbalance. Diet significantly influences the microbiota; high-fat, high-sugar diets can foster the growth of harmful bacteria, whereas fibre-rich diets support beneficial microbes. Gastrointestinal infections can disrupt the microbiota and allow pathogen overgrowth. Chronic diseases, such as autoimmune disorders and cancers, can alter microbial communities directly through disease mechanisms or indirectly through treatments like chemotherapy. In summary, dysbiosis is a multifaceted condition influenced by numerous factors and linked to various diseases beyond the gastrointestinal tract. Understanding the complex relationships between the microbiota and host health is essential for developing targeted therapies to restore microbial balance and treat dysbiosis-related diseases.